logo

Deposit $200 to get a $100 trading bonus.

Use the promo code AMANAWEB.

Sign up now.*T&Cs Apply.

Terms & Conditions

  1. Offer valid for new users signing up on amana.
  2. How to Qualify for $100 Trading Bonus:
    • Sign up via the website.
    • Complete onboarding by providing the required details.
    • Enter promo code AMANAWEB at the final step.
    • Deposit $100 or more before your first trade.
    • Make your first trade.
  3. Once all steps are completed, you’ll receive a $100 non-withdrawable trading bonus.
  4. Bonuses are credited during the first week of every month.
  5. The bonus can only be used for trading and cannot be withdrawn.
  6. The campaign is exclusive to selected amana customers.
  7. amana reserves the right to cancel bonuses in cases of suspected fraud.
EDIT icon

EDIT

Lightning icon

2.85 USD

-3.45%

Today

+0.72%

1D

Market is open

Sun

Closed

Mon

3:00 AM ~ 12:00 PM

Tue

12:00 AM ~ 12:00 PM

Wed

12:00 AM ~ 12:00 PM

Thu

12:00 AM ~ 12:00 PM

Fri

12:00 AM ~ 12:00 PM

Sat

Closed

Loading chart...
1D
5D
1M
3M
1Y
MAX

Information

Name

Editas Medicine Leveraged

Currency

USD

Standard Leverage

1X

Lightning Icon

Enhanced Leverage

3X

Lightning Icon

Overnight Fees Buy

-0.0183%

Overnight Fees Sell

0.0016%

Market Cap

442.31M

Avg Daily Volume

2.54M

52 Week High

4.537 USD

52 Week Low

1.66 USD

Trading Hours

See hours

Overnight Fees Calculator

ExposureUnits
USD
Daily Overnight Fee %Daily Overnight Fee $
BUYS-0.01830%$(0.183)
SELLS0.00160%$0.016

*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.

Business Summary

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalassemia; and in vivo gene editing medicines indicated for other cells and tissues. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors, and autoimmune disease. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

Top News

Editas-Medicine

+0.72%

EDIT: Director elections, compensation, and auditor ratification passed; EDIT-401 clinical plans advanced

tradingview.com

1mo ago

No Image

Editas-Medicine

+0.72%

EDIT: Directors elected, EDIT-401 progress and funding announced, no stockholder questions

tradingview.com

1mo ago

No Image

Editas-Medicine

+0.72%

EDIT: EDIT-401 shows durable 90% LDL and Lp(a) reduction, with clinical trials starting in 2024

tradingview.com

2mo ago

No Image

Show more

Frequently Asked Questions

What are healthcare stocks and why are they important to investors?

Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.

Are healthcare stocks less volatile?

Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.

What drives growth in healthcare investments?

Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.

What are the risks of investing in healthcare?

Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.